With advanced oncology infrastructure, Primus Super Speciality Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2001, the NABH accredited hospital is located in Delhi, India, and has 250 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.